Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
| Last: | $95.51 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $95.51 |
| Close: | $95.51 |
| High: | $95.51 |
| Low: | $95.51 |
| Volume: | 100 |
| Last Trade Date Time: | 02/10/2026 10:15:27 am |
| Market Cap: | $24,360,947,456 |
|---|---|
| Float: | 255,061,747 |
| Insiders Ownership: | N/A |
| Institutions: | 140 |
| Short Percent: | N/A |
| Industry: | Industrial Goods |
| Sector: | Industrials |
| Website: | http://www.organo.co.jp |
| Country: | JP |
| City: | Tokyo |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Organo (OTCMKTS: ORGJF).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.